Acadian Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $8.7M | Buy |
|
|||||
|
2025
Q2 | $2.52M | Sell |
|
|||||
|
2025
Q1 | $2.42M | Sell |
|
|||||
|
2024
Q4 | $3.92M | Sell |
|
|||||
|
2024
Q3 | $9.46M | Sell |
|
|||||
|
2024
Q2 | $9.06M | Buy |
|
|||||
|
2024
Q1 | $247K | Buy |
|
|||||
|
2023
Q4 | $243K | Buy |
|
|||||
|
2023
Q3 | $160K | Buy |
|
|||||
|
2023
Q2 | $112K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $217K | Hold |
|
|||||
|
2022
Q3 | $182K | Buy |
|